Neurocrine Biosciences names Eiry W. Roberts chief medical officer, replacing Sanjay Keswani

Bitget2026/09/28 20:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Neurocrine Biosciences named Eiry W. Roberts as chief medical officer, effective immediately.
Sanjay Keswani will leave the company under a mutual agreement.
Roberts previously served as chief medical officer from 2018 to 2025, most recently acting as a strategic advisor.
She spent 26 years at Eli Lilly, including as vice president of research and development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609281605PR_NEWS_USPR_____LA58413) on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Neurocrine Biosciences names Eiry W. Roberts chief medical officer, replacing Sanjay Keswani

You may also like

Crypto prices